Sumitomo Chemi.

What does Sumitomo Chemi. do?

Sumitomo Chemical India Ltd manufactures household insecticides, agricultural pesticides, public health insecticides, and animal nutrition products. As of March 2025, it reported net sales of ₹679 Cr and a net profit of ₹100 Cr, with a market cap of ₹25,853 Cr.

Overview: <BR>Sumitomo Chemical India Ltd is engaged in the manufacturing of household insecticides, agricultural pesticides, public health insecticides, and animal nutrition products, operating within the Pesticides & Agrochemicals industry and classified as a Large Cap company.<BR><BR>History: <BR>Sumitomo Chemical India Ltd was incorporated on 15 February 2000 and transitioned from Private Limited to Public Limited status on 24 November 2018. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 679 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 100 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 25,853 Cr (Large Cap)<BR><BR>Key Metrics: <BR>P/E: 51.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.17% <BR>Debt-Equity: -0.15 <BR>Return on Equity: 17.42% <BR>Price to Book: 8.90 <BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Who are in the management team of Sumitomo Chemi.?

As of March 2022, the management team of Sumitomo Chemi includes Mukul G Asher (Chairman), Chetan Shah (Managing Director), and several directors and officers responsible for the company's operations and strategy.

As of March 2022, the management team of Sumitomo Chemi includes the following individuals:<BR><BR>1. Mukul G Asher - Chairman & Independent Director<BR>2. Chetan Shah - Managing Director<BR>3. B V Bhargava - Independent Director<BR>4. Ninad D Gupta - Director<BR>5. Preeti Mehta - Independent Director<BR>6. Sushil Marfatia - Executive Director<BR>7. Masanori Uzawa - Director<BR>8. Suresh Ramachandran - Whole-time Director<BR>9. Deepika Trivedi - Company Secretary & Compliance Officer<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Has Sumitomo Chemi. declared dividend?

Yes, Sumitomo Chemical India Ltd has declared a 9% dividend (₹0.9 per share) with an ex-date of July 19, 2024. While recent performance shows mixed returns, the company has demonstrated positive growth over the longer term, especially with a total return of 92.31% over the past five years.

Yes, Sumitomo Chemical India Ltd has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 9%<BR>- Amount per share: 0.9<BR>- Ex-date: 19 Jul 24<BR><BR>Dividend Yield: 0.17%.<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -6.03%, with a dividend return of 0%, resulting in a total return of -6.03%.<BR><BR>For the 1-year period, the price return was 8.21%, the dividend return was 0.18%, leading to a total return of 8.39%.<BR><BR>Over the 2-year period, the price return was 25.17%, the dividend return was 1.66%, resulting in a total return of 26.83%.<BR><BR>In the 3-year period, the price return was 7.24%, the dividend return was 1.98%, culminating in a total return of 9.22%.<BR><BR>During the 4-year period, the price return was 45.11%, with a dividend return of 2.30%, giving a total return of 47.41%.<BR><BR>For the 5-year period, the price return was 88.86%, the dividend return was 3.45%, resulting in a total return of 92.31%.<BR><BR>Overall, Sumitomo Chemical India Ltd has declared a dividend, and while the recent performance shows mixed returns, the longer-term trends indicate positive growth, particularly over the 5-year period.

Who are the peers of the Sumitomo Chemi.?

Sumitomo Chemi.'s peers include P I Industries, UPL, Bayer CropSci., Dhanuka Agritech, Sharda Cropchem, Rallis India, Bhagiradha Chem., Bharat Rasayan, and NACL Industries. Dhanuka Agritech shows the highest growth and return, while Bharat Rasayan has the lowest return, with Sumitomo Chemi. achieving an 8.51% return.

Peers: The peers of Sumitomo Chemi. are P I Industries, UPL, Bayer CropSci., Dhanuka Agritech, Sharda Cropchem, Rallis India, Bhagiradha Chem., Bharat Rasayan, and NACL Industries.<BR><BR>Quality Snapshot: Excellent management risk is observed at Bayer CropSci. and Dhanuka Agritech, while Good management risk is found at P I Industries, Sumitomo Chemi., Sharda Cropchem, and Bharat Rasayan, and the rest have Average management risk. Growth is Excellent at Dhanuka Agritech, while Excellent capital structure is noted for P I Industries, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, Rallis India, and Bharat Rasayan, with the rest showing Below Average growth and Below Average capital structure.<BR><BR>Return Snapshot: Dhanuka Agritech has the highest 1-year return at 32.65%, while Bharat Rasayan has the lowest at -12.17%, with Sumitomo Chemi.'s 1-year return at 8.51% being higher than Bharat Rasayan's but lower than Dhanuka Agritech's. Additionally, UPL, Bhagiradha Chem., Bharat Rasayan, and NACL Industries have negative six-month returns.

Is Sumitomo Chemi. overvalued or undervalued?

As of February 14, 2020, Sumitomo Chemical India Ltd. is considered very expensive and overvalued, with a PE ratio of 51.25 and a Price to Book Value of 8.93, despite a strong ROCE of 23.07%, indicating it trades at a premium compared to its peers and has underperformed in longer-term returns.

As of 14 February 2020, the valuation grade for Sumitomo Chemical India Ltd. has moved from does not qualify to very expensive, indicating a significant shift in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 51.25, a Price to Book Value of 8.93, and an EV to EBITDA of 40.28, all of which suggest that the stock is trading at a premium compared to its earnings and asset values.<BR><BR>In comparison to its peers, Sumitomo Chemical India Ltd. stands out with a PE ratio of 51.25, while its closest competitor has a lower valuation, reinforcing its overvalued status. Additionally, the company's return on capital employed (ROCE) is a strong 23.07%, but this does not offset the high valuation metrics. Notably, while the stock has outperformed the Sensex over the past week and month, it has lagged behind in year-to-date and longer-term returns, further supporting the conclusion that it is overvalued in the current market context.

Who are the top shareholders of the Sumitomo Chemi.?

The top shareholders of Sumitomo Chemical include Sumitomo Chemical Co. Ltd. with 75.0%, mutual funds with 6.27%, foreign institutional investors at 3.63%, HSBC Small Cap Fund as the largest public shareholder at 1.09%, and individual investors holding 10.14%. This indicates a strong promoter presence in the company.

The top shareholders of Sumitomo Chemical include the following:<BR><BR>1. **Promoter with the highest holding**: Sumitomo Chemical Co. Ltd., which holds 75.0% of the shares.<BR>2. **Mutual Funds**: A total of 30 schemes collectively hold 6.27%.<BR>3. **Foreign Institutional Investors (FIIs)**: 131 FIIs hold 3.63%.<BR>4. **Highest Public Shareholder**: HSBC Small Cap Fund, with a holding of 1.09%.<BR>5. **Individual Investors**: They collectively hold 10.14% of the shares.<BR><BR>This distribution highlights a strong promoter presence in the company, particularly from Sumitomo Chemical Co. Ltd.

How big is Sumitomo Chemi.?

As of 24th July, Sumitomo Chemical India Ltd has a market capitalization of 29,450.00 Cr, with recent Net Sales of 3,148.53 Cr and a Net Profit of 505.50 Cr.

As of 24th July, Sumitomo Chemical India Ltd has a market capitalization of 29,450.00 Cr, categorizing it as a Large Cap company.<BR><BR>For the latest four quarters, the company reported Net Sales of 3,148.53 Cr and a Net Profit of 505.50 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 2,901.14 Cr and Total Assets of 3,963.28 Cr.

How has been the historical performance of Sumitomo Chemi.?

Sumitomo Chemi experienced significant fluctuations in financial performance from March 2019 to March 2025, with net sales and operating income dropping to zero by March 2025, while maintaining a strong asset base and achieving profitability in profit before tax and profit after tax. Despite operational losses, total assets grew from 3,368.71 Cr to 3,963.28 Cr during this period.

Answer:<BR>The historical performance of Sumitomo Chemi shows significant fluctuations in key financial metrics over the years, particularly from March 2019 to March 2025.<BR><BR>Breakdown:<BR>Sumitomo Chemi's net sales peaked at 3,510.97 Cr in March 2023 but dropped to 0.00 Cr by March 2025. The total operating income followed a similar trend, decreasing from 3,510.97 Cr in March 2023 to 0.00 Cr in March 2025. The company's total expenditure, excluding depreciation, was 2,844.37 Cr in March 2023 and increased to 2,516.47 Cr in March 2025. Operating profit (PBDIT) showed a decline from 711.45 Cr in March 2023 to -2,516.47 Cr in March 2025, indicating a significant operational loss. Despite this, profit before tax improved from 654.18 Cr in March 2023 to 680.24 Cr in March 2025, while profit after tax also saw an increase from 502.21 Cr to 506.44 Cr in the same period. The company's total assets grew from 3,368.71 Cr in March 2023 to 3,963.28 Cr in March 2025, reflecting a strong asset base despite the operational challenges. Cash flow from operating activities decreased from 757.00 Cr in March 2024 to 452.00 Cr in March 2025, and the net cash outflow was recorded at -8.00 Cr in March 2025. Overall, while Sumitomo Chemi faced operational difficulties leading to losses, it maintained a solid asset position and managed to achieve profitability in terms of tax and net profit.

Is Sumitomo Chemi. technically bullish or bearish?

As of November 14, 2025, the technical trend has shifted to a moderately strong bearish stance, indicated by bearish MACD, Bollinger Bands, and moving averages, along with significant underperformance compared to the Sensex.

As of 14 November 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include a bearish MACD on the weekly chart, bearish Bollinger Bands on both weekly and monthly time frames, and bearish moving averages on the daily chart. The KST and Dow Theory are also indicating bearish trends on the weekly, while the monthly signals are mildly bearish. The stock has underperformed significantly compared to the Sensex over various periods, further supporting the bearish outlook.

Are Sumitomo Chemical India Ltd latest results good or bad?

Sumitomo Chemical India Ltd's latest results are poor, with a 57.46% decline in net profit to ₹75.63 crore and a 38.92% drop in revenue to ₹567.98 crore compared to the previous quarter. The company faces significant margin compression and bearish stock indicators, suggesting caution for investors.

The latest results for Sumitomo Chemical India Ltd indicate a challenging quarter. In Q3 FY26, the company reported a net profit of ₹75.63 crore, which represents a significant decline of 57.46% compared to the previous quarter. Revenue also saw a sharp drop, falling to ₹567.98 crore, down 38.92% QoQ and 11.52% year-on-year. This decline marks the lowest quarterly revenue in the current fiscal year, highlighting the cyclical nature of the agrochemical business, particularly in the traditionally weaker Q3 period.<BR><BR>Additionally, both operating and profit after tax margins contracted considerably, with the operating margin decreasing to 17.52% from 23.45% in the previous quarter. This margin compression reflects pricing pressures and challenges in adjusting costs in line with the revenue decline.<BR><BR>Overall, the results can be characterized as poor, with significant declines in both profit and revenue, alongside deteriorating margins. The company's technical indicators also suggest a bearish trend, as the stock has been trading below key moving averages. Investors should be cautious, given these financial challenges and the elevated valuation multiples that may not be justified by the current growth trajectory.

Should I buy, sell or hold Sumitomo Chemical India Ltd?

When is the next results date for Sumitomo Chemical India Ltd?

The next results date for Sumitomo Chemical India Ltd is 26 May 2026.

The next results date for Sumitomo Chemical India Ltd is scheduled for 26 May 2026.

Which are the latest news on Sumitomo Chemi.?

Why is Sumitomo Chemical India Ltd falling/rising?

As of 20-May, Sumitomo Chemical India Ltd's stock price is declining, currently at Rs 460.80, reflecting a 1.87% decrease. The stock has underperformed due to disappointing financial results, poor growth prospects, and high valuation compared to peers.

As of 20-May, Sumitomo Chemical India Ltd's stock price is falling, currently at Rs 460.80, which reflects a decrease of Rs 8.8 or 1.87%. The stock has underperformed the sector today by 2.22%, and it reached an intraday low of Rs 458.7, marking a decline of 2.32%. <BR><BR>Over the past year, the stock has generated a return of -14.27%, significantly underperforming the broader market, which saw a negative return of -0.60%. This poor performance is attributed to several factors, including a lack of long-term growth, with net sales growing at an annual rate of only 4.81% and operating profit at 7.50% over the last five years. Additionally, the company reported disappointing quarterly results, with a PAT of Rs 87.65 crore falling by 35.4% compared to the previous four-quarter average, and net sales at their lowest of Rs 567.98 crore.<BR><BR>Despite having a high return on equity (ROE) of 18.58% and being net-debt free, the stock is considered expensive with a price-to-book value of 7.2, which is above the average historical valuations of its peers. The PEG ratio of 7.9 further indicates that the stock may be overvalued relative to its earnings growth. <BR><BR>In summary, the combination of disappointing financial results, poor long-term growth prospects, and an expensive valuation compared to peers has contributed to the decline in Sumitomo Chemical India Ltd's stock price.